Omar Y. Mian, M.D., Ph.D.
Omar Y. Mian, M.D., Ph.D.
Translational Hematology and Oncology Research, Cleveland Clinic
Verified email at - Homepage
Cited by
Cited by
Targeted disruption of p53 attenuates doxorubicin-induced cardiac toxicity in mice
Y Shizukuda, S Matoba, OY Mian, T Nguyen, PM Hwang
Molecular and cellular biochemistry 273, 25-32, 2005
NCCN guidelines« insights: bladder cancer, version 2.2022: featured updates to the NCCN guidelines
TW Flaig, PE Spiess, M Abern, N Agarwal, R Bangs, SA Boorjian, ...
Journal of the National Comprehensive Cancer Network 20 (8), 866-878, 2022
Circulating transcriptome reveals markers of atherosclerosis
WD Patino, OY Mian, JG Kang, S Matoba, LD Bartlett, B Holbrook, ...
Proceedings of the National Academy of Sciences 102 (9), 3423-3428, 2005
Molecular characterization of neuroendocrine-like bladder cancer
J Batista da Costa, EA Gibb, TJ Bivalacqua, Y Liu, HZ Oo, DT Miyamoto, ...
Clinical cancer research 25 (13), 3908-3920, 2019
Serial analysis of gene expression: technical considerations and applications to cardiovascular biology
WD Patino, OY Mian, PM Hwang
Circulation research 91 (7), 565-569, 2002
Resistance to targeted therapies as a multifactorial, gradual adaptation to inhibitor specific selective pressures
R Vander Velde, N Yoon, V Marusyk, A Durmaz, A Dhawan, ...
Nature communications 11 (1), 2393, 2020
Atherosclerotic plaque macrophage transcriptional regulators are expressed in blood and modulated by tristetraprolin
WD Patino, JG Kang, S Matoba, OY Mian, BR Gochuico, PM Hwang
Circulation research 98 (10), 1282-1289, 2006
GSTP1 Loss results in accumulation of oxidative DNA base damage and promotes prostate cancer cell survival following exposure to protracted oxidative stress
OY Mian, MH Khattab, M Hedayati, J Coulter, B Abubaker‐Sharif, ...
The Prostate 76 (2), 199-206, 2016
Methyl-binding domain protein 2–dependent proliferation and survival of breast cancer cells
OY Mian, SZ Wang, SZ Zhu, MN Gnanapragasam, L Graham, HD Bear, ...
Molecular Cancer Research 9 (8), 1152-1162, 2011
Transcriptomic and protein analysis of small-cell bladder cancer (SCBC) identifies prognostic biomarkers and DLL3 as a relevant therapeutic target
VS Koshkin, JA Garcia, J Reynolds, P Elson, C Magi-Galluzzi, ...
Clinical Cancer Research 25 (1), 210-221, 2019
A Therapeutic Strategy for Preferential Targeting of TET2-Mutant and TET Dioxygenase–Deficient Cells in Myeloid Neoplasms
Y Guan, AD Tiwari, JG Phillips, M Hasipek, DR Grabowski, S Pagliuca, ...
Blood cancer discovery 2 (2), 146-161, 2021
The role of the epigenetic signal, DNA methylation, in gene regulation during erythroid development
GD Ginder, MN Gnanapragasam, OY Mian
Current topics in developmental biology 82, 85-116, 2008
Patients with muscle-invasive bladder cancer with nonluminal subtype derive greatest benefit from platinum based neoadjuvant chemotherapy
Y Lotan, JJ De Jong, VYT Liu, TA Bismar, SA Boorjian, HC Huang, ...
The Journal of Urology 207 (3), 541-550, 2022
Androgen deprivation followed by acute androgen stimulation selectively sensitizes AR-positive prostate cancer cells to ionizing radiation
M Hedayati, MC Haffner, JB Coulter, RR Raval, Y Zhang, H Zhou, O Mian, ...
Clinical Cancer Research 22 (13), 3310-3319, 2016
Management options in locally advanced pancreatic cancer
OY Mian, AN Ram, R Tuli, JM Herman
Current oncology reports 16, 1-12, 2014
Impact of cribriform pattern and intraductal carcinoma on Gleason 7 prostate cancer treated with external beam radiotherapy
MC Tom, JK Nguyen, R Lucian˛, OY Mian, KL Stephans, JP Ciezki, ...
The Journal of Urology 202 (4), 710-716, 2019
Correlation between MRI phenotypes and a genomic classifier of prostate cancer: preliminary findings
AS Purysko, C Magi-Galluzzi, OY Mian, S Sittenfeld, E Davicioni, ...
European radiology 29, 4861-4870, 2019
Ten-year outcomes of moderately hypofractionated (70 Gy in 28 fractions) intensity modulated radiation therapy for localized prostate cancer
I Abu-Gheida, CA Reddy, R Kotecha, MA Weller, C Shah, PA Kupelian, ...
International Journal of Radiation Oncology* Biology* Physics 104 (2), 325-333, 2019
Case study: patient-derived clear cell adenocarcinoma xenograft model longitudinally predicts treatment response
R Vargas, P Gopal, GB Kuzmishin, R DeBernardo, SA Koyfman, BK Jha, ...
NPJ Precision Oncology 2 (1), 14, 2018
Validation of a neuroendocrine-like classifier confirms poor outcomes in patients with bladder cancer treated with cisplatin-based neoadjuvant chemotherapy
P Grivas, TA Bismar, AS Alva, HC Huang, Y Liu, R Seiler, N Alimohamed, ...
Urologic Oncology: Seminars and Original Investigations 38 (4), 262-268, 2020
The system can't perform the operation now. Try again later.
Articles 1–20